Well MGPI violates one of the rules of bio investing--
It makes money! Lots of it! It's got a freakin' PE of 14 for gods sake this is no up and commer, and as such must be valued as a real entity!
It looks like they lost a big pet food contract last qtr.
If you look at estimates 30 days ago for the current QTR they were 37 cents now 32 cents and full year has come down to $1.40 to $1.45 so there is earnings risk here which you would never have with one of my biotechs- they have no earnings!
This new upgrade today and whatever they said yesterday at Roth must be taken into consideration...
It makes money! Lots of it! It's got a freakin' PE of 14 for gods sake this is no up and commer, and as such must be valued as a real entity!
It looks like they lost a big pet food contract last qtr.
If you look at estimates 30 days ago for the current QTR they were 37 cents now 32 cents and full year has come down to $1.40 to $1.45 so there is earnings risk here which you would never have with one of my biotechs- they have no earnings!
This new upgrade today and whatever they said yesterday at Roth must be taken into consideration...